Paramagnetic aAPC Platform for High-Throughput T Cell Enrichment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying and isolating antigen-specific T cells are challenging due to their low frequency and diversity, requiring complex and labor-intensive procedures that limit throughput and ease of use.
Innovation Solution
Development of adaptive artificial antigen presenting cells (aAPCs) with paramagnetic particles conjugated to MHC or HLA and costimulatory ligands, allowing for the loading of peptides post-conjugation, which are used to enrich and expand antigen-specific T cells using a magnetic field.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods like flow or mass cytometry are used to identify antigen-specific T cells, then detection sensitivity can be improved through techniques like multimerizing MHC or magnetic enrichment, but throughput remains low and procedures become complex and labor-intensive
Solution Approach 1:
The invention segments the aAPC preparation into two distinct stages: (1) conjugating MHC and costimulatory ligands to paramagnetic particles to create adaptable platforms, and (2) loading peptides post-conjugation. This segmentation allows the platform to be prepared once and then rapidly adapted to different antigens, improving throughput while maintaining detection sensitivity through the standardized magnetic separation and detection protocols.
Solution Approach 2:
The invention introduces paramagnetic particles as an intermediary carrier between the MHC-peptide complexes and T cells. These particles enable magnetic enrichment and detection of antigen-specific T cells, combining the sensitivity of MHC multimerization with the throughput advantages of magnetic separation techniques, thereby resolving the contradiction between detection precision and productivity.
2Reliability
If MHC is pre-loaded with peptide prior to conjugation, then antigen specificity is established, but the process becomes complex and difficult to use for high throughput applications
Solution Approach 1:
The invention makes the aAPC system dynamic by allowing peptide loading to occur after MHC conjugation to the paramagnetic particle surface. This dynamic approach enables the same MHC-conjugated particles to be reused with different peptide loads for screening multiple antigens, greatly simplifying the manufacturing process and improving ease of use while maintaining reliable antigen-specific T cell detection.
Solution Approach 2:
The invention performs preliminary conjugation of MHC and costimulatory ligands to the paramagnetic particle surface before peptide loading. This preliminary action creates a stable, reusable platform that requires only simple peptide incubation for antigen loading, eliminating the complexity of pre-loading MHC with peptide and making the system much easier to manufacture and use for high throughput applications.
3Productivity
If complex procedures like UV-cleavable peptides or combinatorial fluorescent labeling are used to improve throughput, then detection capacity increases, but device complexity and difficulty of use increase significantly
Solution Approach 1:
The invention extracts the complexity from the detection system by using simple paramagnetic particles conjugated to MHC and costimulatory ligands, eliminating the need for complex UV-cleavable peptides or combinatorial fluorescent labeling. The magnetic properties of the particles provide straightforward separation and detection, achieving high throughput with minimal procedural complexity.
Solution Approach 2:
The invention changes the detection parameter from complex fluorescent labeling or UV-cleavable chemistry to simple magnetic separation based on the paramagnetic properties of the particles. This parameter change simplifies the procedure significantly while maintaining or improving throughput, as magnetic separation is a straightforward, scalable technique that does not require complex reagents or multiple staining steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the throughput and efficiency of identifying and isolating antigen-specific T cells, improving their purity and expansion while simplifying the process, enabling the detection of rare and low-affinity neoantigen-specific T cells.
Implementation Method 1
conjugating to a surface of a paramagnetic particle a major histocompatibility complex (MHC) or a human leukocyte antigen (HLA) and a costimulatory ligand
Implementation Method 2
placing a magnetic field in proximity to the plurality of adaptive aAPCs and/or the plurality of adaptive detection beads to separate antigen-specific T cells
Implementation Method 3
incubating the conjugated paramagnetic particle with one or more peptides to load the conjugated MHC or HLA on the paramagnetic particle with the one or more peptides
Data Source
AI summary
Disclosed are methods for enriching and expanding antigen-specific T cells with paramagnetic nanoparticles comprising a major histocompatibility complex (MHC) or human leukocyte antigen (HLA) and a costimulatory molecule bound thereto. The platform eliminates the requirement of cell isolation and can be further adapted to be high throughput with the capability of processing multiple antigen-specific T cells in parallel. Accordingly, the disclosed methods provide a high-throughput workflow for the identification and analysis of antigen-specific T cell responses.